Plain-English translation of NCT07538947 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether confocal laser endomicroscopy (CLE)—a specialized real-time imaging tool—can help doctors more accurately identify and diagnose non-small cell lung cancer during bronchoscopic biopsy. Researchers want to see if this imaging technique can improve the accuracy of cancer detection and help doctors take better tissue samples in a single procedure.
Currently, doctors rely on standard biopsy samples sent to a lab for analysis, which can take time and sometimes require repeat procedures if the sample doesn't contain enough diagnostic information. This trial aims to see if real-time imaging during the procedure could help doctors immediately identify cancer and take more targeted samples, potentially making diagnosis faster and safer.
You likely qualify if…
You likely don't qualify if…
You will undergo a standard bronchoscopic biopsy procedure—a examination where a thin camera is passed down your airways to look for abnormal tissue. During this procedure, doctors will use the new real-time imaging technique alongside standard biopsy to examine suspicious areas in your lungs. Your tissue samples will then be analyzed in the lab, and the imaging findings will be compared with the standard biopsy results to see how well the new technique works.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France